Shlobin, Nathan A.
Sander, Josemir W.
Article History
Accepted: 13 April 2022
First Online: 20 May 2022
Declarations
:
: Nathan A. Shlobin received no funding. Josemir W. Sander is based at the NIHR University College London Hospitals Biomedical Research Centre, which receives a proportion of funding from the UK Department of Health’s Research Centres funding scheme. He receives research support from the Dr Marvin Weil Epilepsy Research Fund, from the UK Epilepsy Society, and the Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie, the Netherlands.
: Nathan A. Shlobin has no disclosures to report. Josemir W. Sander reports personal fees from Eisai, UCB, GW, Arvelle, and Zogenix, and grants from UCB outside the submitted work.
: Not required or sought. This was a narrative review of existing literature.
: Not applicable.
: Not applicable.
: All relevant data can be found in the references of this review.
: Not applicable.
: NAS conducted the literature search and data analysis and drafted the manuscript. JWS formulated the concept for the article and provided critical intellectual input. Both authors have read and approved the final submitted manuscript and agree to be accountable for the work.